Publication: Pediatric hereditary angioedema
Open/View Files
Date
2013
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BlackWell Publishing Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
MacGinnitie, Andrew J. 2013. “Pediatric hereditary angioedema.” Pediatric Allergy and Immunology 25 (5): 420-427. doi:10.1111/pai.12168. http://dx.doi.org/10.1111/pai.12168.
Research Data
Abstract
Hereditary angioedema (HAE) is a lifelong illness characterized by recurrent swelling of the skin, intestinal tract, and, ominously, the upper airway. It is caused by inadequate activity of the protein C1-inhibitor, with dysfunction in the kallikrein/bradykinin pathway underlying the clinical symptoms. In addition to the physical symptoms, patients experience significant decrements in vocational and school achievement as well as in overall quality of life. Symptoms often begin in childhood and occur by age 20 in most patients, but life-threatening attacks are uncommon in the pediatric population. The availability of new therapies has transformed the management of HAE.
Description
Other Available Sources
Keywords
angioedema, bradykinin, children, C1-inhibitor, hereditary angioedema
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service